These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18848467)

  • 21. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
    Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
    J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA).
    Klaamas K; Kodar K; Kurtenkov O
    Neoplasma; 2008; 55(2):143-50. PubMed ID: 18237253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
    Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of serum endothelial cell specific molecule 1 in gastric cancer patients and its clinical significance].
    Sun W; Zhang L; Cheng X; Wang X; Xing X; Du H; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):51-5. PubMed ID: 24519050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method.
    Jin B; Wang X; Jin Y; Xia W; Chen B; Liu L; Chen Z; Hong L; Du W; Yan K; Wang H; Yuan D; Hui X; He L; Zhang F; Zhao Y; Wu K; Fan D
    Cancer Invest; 2009 Feb; 27(2):227-33. PubMed ID: 19235597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoradiometric assay of tumor marker CA15-3 and its clinical application].
    Chen Z; Fan Z; Yang J
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):125-8. PubMed ID: 10920962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
    Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
    Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
    Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
    Xu H; Inagaki Y; Tang W; Guo Q; Wang F; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2008; 55(88):2000-4. PubMed ID: 19260467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.
    Alix-Panabières C; Brouillet JP; Fabbro M; Yssel H; Rousset T; Maudelonde T; Choquet-Kastylevsky G; Vendrell JP
    J Immunol Methods; 2005 Apr; 299(1-2):177-88. PubMed ID: 15914200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
    Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
    Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of ApoE expression in human gastric cancer.
    Sakashita K; Tanaka F; Zhang X; Mimori K; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Oncol Rep; 2008 Dec; 20(6):1313-9. PubMed ID: 19020708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas.
    Freire T; Medeiros A; Reis CA; Real FX; Osinaga E
    Oncol Rep; 2003; 10(5):1577-85. PubMed ID: 12883744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of the 45M1 epitope to the C-terminal cysteine-rich part of the human MUC5AC mucin.
    Lidell ME; Bara J; Hansson GC
    FEBS J; 2008 Feb; 275(3):481-9. PubMed ID: 18167142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
    Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
    Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients.
    Wang J; Zhang S; Ni W; Zhai X; Xie F; Yuan H; Gao S; Tai G
    Cancer Biomark; 2016; 17(4):369-376. PubMed ID: 27636855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.